This study investigates advanced solid tumors. The purpose of this study is to evaluate the investigational medication for its effects on these conditions.
The study focuses on assessing the safety, tolerability, and anti-tumor activity of the investigational medication.
- Who can participate: Adults aged 18 and older with metastatic solid tumors and good performance status can participate. Adequate organ function and consent ability are required.
- Study details: Participants will receive an investigational medication to evaluate its effects. Some may receive a placebo.
- Study timelines: The study will last 10 months.
How understandable was the trial content above?
Hard to understand
Easy to understand